These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

82 related items for PubMed ID: 6934024

  • 21. Serum protein reduction of the enhancement of methotrexate accumulation by vincristine and 4'-demethylepipodophyllotoxin in the Ehrlich ascites tumor cell in vitro.
    Gewirtz DA.
    Cancer Res; 1985 Dec; 45(12 Pt 1):6290-2. PubMed ID: 4063980
    [Abstract] [Full Text] [Related]

  • 22. [The correlation of the in vitro 14C-glycine absorption by murine and human leukemic cells with the antitumor effect of vincristine].
    Sidorova TA, Volkova MA.
    Eksp Onkol; 1989 Dec; 11(2):52-4. PubMed ID: 2737131
    [Abstract] [Full Text] [Related]

  • 23. Mode of action of methotrexate-albumin in a human T-cell leukemia line and activity against an MTX-resistant clone.
    Weigand M, Hartung G, Roboz J, Sieger S, Wolf M, Sinn H, Schrenk HH, Wiessler M, Frei E.
    Anticancer Drug Des; 2001 Dec; 16(4-5):227-37. PubMed ID: 12049481
    [Abstract] [Full Text] [Related]

  • 24. Overcoming of vincristine resistance in HL-60 human promyelocytic leukemia cell line by dipyridamole.
    Hirose M, Takeda E, Kuroda Y.
    Tokushima J Exp Med; 1993 Jun; 40(1-2):27-33. PubMed ID: 8211977
    [Abstract] [Full Text] [Related]

  • 25. In vitro validation of gamma-secretase inhibitors alone or in combination with other anti-cancer drugs for the treatment of T-cell acute lymphoblastic leukemia.
    De Keersmaecker K, Lahortiga I, Mentens N, Folens C, Van Neste L, Bekaert S, Vandenberghe P, Odero MD, Marynen P, Cools J.
    Haematologica; 2008 Apr; 93(4):533-42. PubMed ID: 18322257
    [Abstract] [Full Text] [Related]

  • 26. Glutathione S-transferase M1 and multidrug resistance protein 1 act in synergy to protect melanoma cells from vincristine effects.
    Depeille P, Cuq P, Mary S, Passagne I, Evrard A, Cupissol D, Vian L.
    Mol Pharmacol; 2004 Apr; 65(4):897-905. PubMed ID: 15044619
    [Abstract] [Full Text] [Related]

  • 27. Suppression of vincristine-mediated cytotoxic activity by mitoxantrone in human cell lines.
    Ho CK, Au LC, Wang SY.
    Anticancer Res; 1996 Apr; 16(5A):2645-51. PubMed ID: 8917364
    [Abstract] [Full Text] [Related]

  • 28. In vitro combination chemotherapy demonstrating potentiation of vincristine cytotoxicity by prednisolone.
    Rosner F, Hirshaut Y, Grünwald HW, Dietrich M.
    Cancer Res; 1975 Mar; 35(3):700-5. PubMed ID: 1116131
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Characterization of tetrandrine, a potent inhibitor of P-glycoprotein-mediated multidrug resistance.
    Fu L, Liang Y, Deng L, Ding Y, Chen L, Ye Y, Yang X, Pan Q.
    Cancer Chemother Pharmacol; 2004 Apr; 53(4):349-56. PubMed ID: 14666379
    [Abstract] [Full Text] [Related]

  • 31. Delayed growth inhibition of human leukaemic cells in culture following treatment with aminonucleoside of puromycin.
    Novak JF, McMaster JH.
    Cytobios; 1981 Apr; 30(117):49-59. PubMed ID: 6940692
    [Abstract] [Full Text] [Related]

  • 32. Degradation of vincristine by myeloperoxidase and hypochlorous acid in children with acute lymphoblastic leukemia.
    Ozgen U, Türköz Y, Stout M, Ozuğurlu F, Pelik F, Bulut Y, Aslan M, Ravindranath Y, Savaşan S.
    Leuk Res; 2003 Dec; 27(12):1109-13. PubMed ID: 12921949
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Accumulation and release of vinblastine and vincristine by HeLa cells: light microscopic, cinematographic, and biochemical study.
    Lengsfeld AM, Dietrich J, Schultze-Maurer B.
    Cancer Res; 1982 Sep; 42(9):3798-805. PubMed ID: 7105045
    [Abstract] [Full Text] [Related]

  • 35. Vincristine saturation of cellular binding sites and its cytotoxic activity in human lymphoblastic leukemia cells: mechanism of inoculum effect.
    Kobayashi H, Takemura Y, Holland JF, Ohnuma T.
    Biochem Pharmacol; 1998 Apr 15; 55(8):1229-34. PubMed ID: 9719477
    [Abstract] [Full Text] [Related]

  • 36. In vitro and in vivo reversal of multidrug resistance in a human leukemia-resistant cell line by mdr1 antisense oligodeoxynucleotides.
    Cucco C, Calabretta B.
    Cancer Res; 1996 Oct 01; 56(19):4332-7. PubMed ID: 8813118
    [Abstract] [Full Text] [Related]

  • 37. Proteomic analysis reveals a novel role for the actin cytoskeleton in vincristine resistant childhood leukemia--an in vivo study.
    Verrills NM, Liem NL, Liaw TY, Hood BD, Lock RB, Kavallaris M.
    Proteomics; 2006 Mar 01; 6(5):1681-94. PubMed ID: 16456880
    [Abstract] [Full Text] [Related]

  • 38. Phenotypic changes induced by a novel benzophenone derivative and resultant suppression of cell proliferation in the human thymic acute lymphoblastic leukemia cell line HPB-ALL.
    Nakao Y, Matsuda S, Matsui T, Nakagawa T, Koizumi T, Saida T, Fujita T.
    Cancer Res; 1984 Dec 01; 44(12 Pt 1):5836-44. PubMed ID: 6594195
    [Abstract] [Full Text] [Related]

  • 39. The effect of vincristine on methotrexate uptake and inhibition of DNA synthesis by human lymphoblastoid cells.
    Warren RD, Nichols AP, Bender RA.
    Cancer Res; 1977 Sep 01; 37(9):2993-7. PubMed ID: 884658
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.